Global Vaccine Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or 'wild' pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
The Global Info Research report includes an overview of the development of the Vaccine industry chain, the market status of For Adult (Varicella Vaccine, Influenza Vaccine), For Child (Varicella Vaccine, Influenza Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Vaccine.
Regionally, the report analyzes the Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Varicella Vaccine, Influenza Vaccine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Vaccine market.
Regional Analysis: The report involves examining the Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Vaccine:
Company Analysis: Report covers individual Vaccine players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (For Adult, For Child).
Technology Analysis: Report covers specific technologies relevant to Vaccine. It assesses the current state, advancements, and potential future developments in Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Vaccine, with revenue, gross margin and global market share of Vaccine from 2019 to 2024.
Chapter 3, the Vaccine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Vaccine market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Vaccine.
Chapter 13, to describe Vaccine research findings and conclusion.
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or 'wild' pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
The Global Info Research report includes an overview of the development of the Vaccine industry chain, the market status of For Adult (Varicella Vaccine, Influenza Vaccine), For Child (Varicella Vaccine, Influenza Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Vaccine.
Regionally, the report analyzes the Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Varicella Vaccine, Influenza Vaccine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Vaccine market.
Regional Analysis: The report involves examining the Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Vaccine:
Company Analysis: Report covers individual Vaccine players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (For Adult, For Child).
Technology Analysis: Report covers specific technologies relevant to Vaccine. It assesses the current state, advancements, and potential future developments in Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Varicella Vaccine
- Influenza Vaccine
- Polio Vaccine
- Hepatitis A Vaccine
- Rabies Vaccine
- BCG Vaccine
- Hepatitis B
- Pertussis, Diphtheria, Tetanus
- Pneumococcal
- Others
- For Adult
- For Child
- AstraZeneca
- BioNTech
- Boehringer-Ingelheim
- CCBIO
- CSL
- CureVac
- Elanco
- GSK
- Hulan Bio
- Indian Immunologicals
- Merck
- Minhai Biotechnology
- Mitsubishi Tanabe Pharma
- Moderna Therapeutics
- Mylan
- Plumbline Life Sciences
- Sanofi
- Translate Bio
- Walvax Biotechnology
- Wuhan Institute of Biological Products
- Zoties
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Vaccine, with revenue, gross margin and global market share of Vaccine from 2019 to 2024.
Chapter 3, the Vaccine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Vaccine market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Vaccine.
Chapter 13, to describe Vaccine research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Vaccine by Type
1.3.1 Overview: Global Vaccine Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Vaccine Consumption Value Market Share by Type in 2023
1.3.3 Varicella Vaccine
1.3.4 Influenza Vaccine
1.3.5 Polio Vaccine
1.3.6 Hepatitis A Vaccine
1.3.7 Rabies Vaccine
1.3.8 BCG Vaccine
1.3.9 Hepatitis B
1.3.10 Pertussis, Diphtheria, Tetanus
1.3.11 Pneumococcal
1.3.12 Others
1.4 Global Vaccine Market by Application
1.4.1 Overview: Global Vaccine Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 For Adult
1.4.3 For Child
1.5 Global Vaccine Market Size & Forecast
1.6 Global Vaccine Market Size and Forecast by Region
1.6.1 Global Vaccine Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Vaccine Market Size by Region, (2019-2030)
1.6.3 North America Vaccine Market Size and Prospect (2019-2030)
1.6.4 Europe Vaccine Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Vaccine Market Size and Prospect (2019-2030)
1.6.6 South America Vaccine Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Vaccine Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Vaccine Product and Solutions
2.1.4 AstraZeneca Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 AstraZeneca Recent Developments and Future Plans
2.2 BioNTech
2.2.1 BioNTech Details
2.2.2 BioNTech Major Business
2.2.3 BioNTech Vaccine Product and Solutions
2.2.4 BioNTech Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 BioNTech Recent Developments and Future Plans
2.3 Boehringer-Ingelheim
2.3.1 Boehringer-Ingelheim Details
2.3.2 Boehringer-Ingelheim Major Business
2.3.3 Boehringer-Ingelheim Vaccine Product and Solutions
2.3.4 Boehringer-Ingelheim Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Boehringer-Ingelheim Recent Developments and Future Plans
2.4 CCBIO
2.4.1 CCBIO Details
2.4.2 CCBIO Major Business
2.4.3 CCBIO Vaccine Product and Solutions
2.4.4 CCBIO Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 CCBIO Recent Developments and Future Plans
2.5 CSL
2.5.1 CSL Details
2.5.2 CSL Major Business
2.5.3 CSL Vaccine Product and Solutions
2.5.4 CSL Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 CSL Recent Developments and Future Plans
2.6 CureVac
2.6.1 CureVac Details
2.6.2 CureVac Major Business
2.6.3 CureVac Vaccine Product and Solutions
2.6.4 CureVac Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 CureVac Recent Developments and Future Plans
2.7 Elanco
2.7.1 Elanco Details
2.7.2 Elanco Major Business
2.7.3 Elanco Vaccine Product and Solutions
2.7.4 Elanco Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Elanco Recent Developments and Future Plans
2.8 GSK
2.8.1 GSK Details
2.8.2 GSK Major Business
2.8.3 GSK Vaccine Product and Solutions
2.8.4 GSK Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 GSK Recent Developments and Future Plans
2.9 Hulan Bio
2.9.1 Hulan Bio Details
2.9.2 Hulan Bio Major Business
2.9.3 Hulan Bio Vaccine Product and Solutions
2.9.4 Hulan Bio Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Hulan Bio Recent Developments and Future Plans
2.10 Indian Immunologicals
2.10.1 Indian Immunologicals Details
2.10.2 Indian Immunologicals Major Business
2.10.3 Indian Immunologicals Vaccine Product and Solutions
2.10.4 Indian Immunologicals Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Indian Immunologicals Recent Developments and Future Plans
2.11 Merck
2.11.1 Merck Details
2.11.2 Merck Major Business
2.11.3 Merck Vaccine Product and Solutions
2.11.4 Merck Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Merck Recent Developments and Future Plans
2.12 Minhai Biotechnology
2.12.1 Minhai Biotechnology Details
2.12.2 Minhai Biotechnology Major Business
2.12.3 Minhai Biotechnology Vaccine Product and Solutions
2.12.4 Minhai Biotechnology Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Minhai Biotechnology Recent Developments and Future Plans
2.13 Mitsubishi Tanabe Pharma
2.13.1 Mitsubishi Tanabe Pharma Details
2.13.2 Mitsubishi Tanabe Pharma Major Business
2.13.3 Mitsubishi Tanabe Pharma Vaccine Product and Solutions
2.13.4 Mitsubishi Tanabe Pharma Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Mitsubishi Tanabe Pharma Recent Developments and Future Plans
2.14 Moderna Therapeutics
2.14.1 Moderna Therapeutics Details
2.14.2 Moderna Therapeutics Major Business
2.14.3 Moderna Therapeutics Vaccine Product and Solutions
2.14.4 Moderna Therapeutics Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Moderna Therapeutics Recent Developments and Future Plans
2.15 Mylan
2.15.1 Mylan Details
2.15.2 Mylan Major Business
2.15.3 Mylan Vaccine Product and Solutions
2.15.4 Mylan Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Mylan Recent Developments and Future Plans
2.16 Plumbline Life Sciences
2.16.1 Plumbline Life Sciences Details
2.16.2 Plumbline Life Sciences Major Business
2.16.3 Plumbline Life Sciences Vaccine Product and Solutions
2.16.4 Plumbline Life Sciences Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Plumbline Life Sciences Recent Developments and Future Plans
2.17 Sanofi
2.17.1 Sanofi Details
2.17.2 Sanofi Major Business
2.17.3 Sanofi Vaccine Product and Solutions
2.17.4 Sanofi Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Sanofi Recent Developments and Future Plans
2.18 Translate Bio
2.18.1 Translate Bio Details
2.18.2 Translate Bio Major Business
2.18.3 Translate Bio Vaccine Product and Solutions
2.18.4 Translate Bio Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Translate Bio Recent Developments and Future Plans
2.19 Walvax Biotechnology
2.19.1 Walvax Biotechnology Details
2.19.2 Walvax Biotechnology Major Business
2.19.3 Walvax Biotechnology Vaccine Product and Solutions
2.19.4 Walvax Biotechnology Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Walvax Biotechnology Recent Developments and Future Plans
2.20 Wuhan Institute of Biological Products
2.20.1 Wuhan Institute of Biological Products Details
2.20.2 Wuhan Institute of Biological Products Major Business
2.20.3 Wuhan Institute of Biological Products Vaccine Product and Solutions
2.20.4 Wuhan Institute of Biological Products Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Wuhan Institute of Biological Products Recent Developments and Future Plans
2.21 Zoties
2.21.1 Zoties Details
2.21.2 Zoties Major Business
2.21.3 Zoties Vaccine Product and Solutions
2.21.4 Zoties Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 Zoties Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Vaccine Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Vaccine by Company Revenue
3.2.2 Top 3 Vaccine Players Market Share in 2023
3.2.3 Top 6 Vaccine Players Market Share in 2023
3.3 Vaccine Market: Overall Company Footprint Analysis
3.3.1 Vaccine Market: Region Footprint
3.3.2 Vaccine Market: Company Product Type Footprint
3.3.3 Vaccine Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Vaccine Consumption Value and Market Share by Type (2019-2024)
4.2 Global Vaccine Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Vaccine Consumption Value Market Share by Application (2019-2024)
5.2 Global Vaccine Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Vaccine Consumption Value by Type (2019-2030)
6.2 North America Vaccine Consumption Value by Application (2019-2030)
6.3 North America Vaccine Market Size by Country
6.3.1 North America Vaccine Consumption Value by Country (2019-2030)
6.3.2 United States Vaccine Market Size and Forecast (2019-2030)
6.3.3 Canada Vaccine Market Size and Forecast (2019-2030)
6.3.4 Mexico Vaccine Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Vaccine Consumption Value by Type (2019-2030)
7.2 Europe Vaccine Consumption Value by Application (2019-2030)
7.3 Europe Vaccine Market Size by Country
7.3.1 Europe Vaccine Consumption Value by Country (2019-2030)
7.3.2 Germany Vaccine Market Size and Forecast (2019-2030)
7.3.3 France Vaccine Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Vaccine Market Size and Forecast (2019-2030)
7.3.5 Russia Vaccine Market Size and Forecast (2019-2030)
7.3.6 Italy Vaccine Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Vaccine Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Vaccine Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Vaccine Market Size by Region
8.3.1 Asia-Pacific Vaccine Consumption Value by Region (2019-2030)
8.3.2 China Vaccine Market Size and Forecast (2019-2030)
8.3.3 Japan Vaccine Market Size and Forecast (2019-2030)
8.3.4 South Korea Vaccine Market Size and Forecast (2019-2030)
8.3.5 India Vaccine Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Vaccine Market Size and Forecast (2019-2030)
8.3.7 Australia Vaccine Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Vaccine Consumption Value by Type (2019-2030)
9.2 South America Vaccine Consumption Value by Application (2019-2030)
9.3 South America Vaccine Market Size by Country
9.3.1 South America Vaccine Consumption Value by Country (2019-2030)
9.3.2 Brazil Vaccine Market Size and Forecast (2019-2030)
9.3.3 Argentina Vaccine Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Vaccine Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Vaccine Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Vaccine Market Size by Country
10.3.1 Middle East & Africa Vaccine Consumption Value by Country (2019-2030)
10.3.2 Turkey Vaccine Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Vaccine Market Size and Forecast (2019-2030)
10.3.4 UAE Vaccine Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Vaccine Market Drivers
11.2 Vaccine Market Restraints
11.3 Vaccine Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Vaccine Industry Chain
12.2 Vaccine Upstream Analysis
12.3 Vaccine Midstream Analysis
12.4 Vaccine Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Vaccine by Type
1.3.1 Overview: Global Vaccine Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Vaccine Consumption Value Market Share by Type in 2023
1.3.3 Varicella Vaccine
1.3.4 Influenza Vaccine
1.3.5 Polio Vaccine
1.3.6 Hepatitis A Vaccine
1.3.7 Rabies Vaccine
1.3.8 BCG Vaccine
1.3.9 Hepatitis B
1.3.10 Pertussis, Diphtheria, Tetanus
1.3.11 Pneumococcal
1.3.12 Others
1.4 Global Vaccine Market by Application
1.4.1 Overview: Global Vaccine Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 For Adult
1.4.3 For Child
1.5 Global Vaccine Market Size & Forecast
1.6 Global Vaccine Market Size and Forecast by Region
1.6.1 Global Vaccine Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Vaccine Market Size by Region, (2019-2030)
1.6.3 North America Vaccine Market Size and Prospect (2019-2030)
1.6.4 Europe Vaccine Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Vaccine Market Size and Prospect (2019-2030)
1.6.6 South America Vaccine Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Vaccine Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Vaccine Product and Solutions
2.1.4 AstraZeneca Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 AstraZeneca Recent Developments and Future Plans
2.2 BioNTech
2.2.1 BioNTech Details
2.2.2 BioNTech Major Business
2.2.3 BioNTech Vaccine Product and Solutions
2.2.4 BioNTech Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 BioNTech Recent Developments and Future Plans
2.3 Boehringer-Ingelheim
2.3.1 Boehringer-Ingelheim Details
2.3.2 Boehringer-Ingelheim Major Business
2.3.3 Boehringer-Ingelheim Vaccine Product and Solutions
2.3.4 Boehringer-Ingelheim Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Boehringer-Ingelheim Recent Developments and Future Plans
2.4 CCBIO
2.4.1 CCBIO Details
2.4.2 CCBIO Major Business
2.4.3 CCBIO Vaccine Product and Solutions
2.4.4 CCBIO Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 CCBIO Recent Developments and Future Plans
2.5 CSL
2.5.1 CSL Details
2.5.2 CSL Major Business
2.5.3 CSL Vaccine Product and Solutions
2.5.4 CSL Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 CSL Recent Developments and Future Plans
2.6 CureVac
2.6.1 CureVac Details
2.6.2 CureVac Major Business
2.6.3 CureVac Vaccine Product and Solutions
2.6.4 CureVac Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 CureVac Recent Developments and Future Plans
2.7 Elanco
2.7.1 Elanco Details
2.7.2 Elanco Major Business
2.7.3 Elanco Vaccine Product and Solutions
2.7.4 Elanco Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Elanco Recent Developments and Future Plans
2.8 GSK
2.8.1 GSK Details
2.8.2 GSK Major Business
2.8.3 GSK Vaccine Product and Solutions
2.8.4 GSK Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 GSK Recent Developments and Future Plans
2.9 Hulan Bio
2.9.1 Hulan Bio Details
2.9.2 Hulan Bio Major Business
2.9.3 Hulan Bio Vaccine Product and Solutions
2.9.4 Hulan Bio Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Hulan Bio Recent Developments and Future Plans
2.10 Indian Immunologicals
2.10.1 Indian Immunologicals Details
2.10.2 Indian Immunologicals Major Business
2.10.3 Indian Immunologicals Vaccine Product and Solutions
2.10.4 Indian Immunologicals Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Indian Immunologicals Recent Developments and Future Plans
2.11 Merck
2.11.1 Merck Details
2.11.2 Merck Major Business
2.11.3 Merck Vaccine Product and Solutions
2.11.4 Merck Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Merck Recent Developments and Future Plans
2.12 Minhai Biotechnology
2.12.1 Minhai Biotechnology Details
2.12.2 Minhai Biotechnology Major Business
2.12.3 Minhai Biotechnology Vaccine Product and Solutions
2.12.4 Minhai Biotechnology Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Minhai Biotechnology Recent Developments and Future Plans
2.13 Mitsubishi Tanabe Pharma
2.13.1 Mitsubishi Tanabe Pharma Details
2.13.2 Mitsubishi Tanabe Pharma Major Business
2.13.3 Mitsubishi Tanabe Pharma Vaccine Product and Solutions
2.13.4 Mitsubishi Tanabe Pharma Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Mitsubishi Tanabe Pharma Recent Developments and Future Plans
2.14 Moderna Therapeutics
2.14.1 Moderna Therapeutics Details
2.14.2 Moderna Therapeutics Major Business
2.14.3 Moderna Therapeutics Vaccine Product and Solutions
2.14.4 Moderna Therapeutics Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Moderna Therapeutics Recent Developments and Future Plans
2.15 Mylan
2.15.1 Mylan Details
2.15.2 Mylan Major Business
2.15.3 Mylan Vaccine Product and Solutions
2.15.4 Mylan Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Mylan Recent Developments and Future Plans
2.16 Plumbline Life Sciences
2.16.1 Plumbline Life Sciences Details
2.16.2 Plumbline Life Sciences Major Business
2.16.3 Plumbline Life Sciences Vaccine Product and Solutions
2.16.4 Plumbline Life Sciences Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Plumbline Life Sciences Recent Developments and Future Plans
2.17 Sanofi
2.17.1 Sanofi Details
2.17.2 Sanofi Major Business
2.17.3 Sanofi Vaccine Product and Solutions
2.17.4 Sanofi Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Sanofi Recent Developments and Future Plans
2.18 Translate Bio
2.18.1 Translate Bio Details
2.18.2 Translate Bio Major Business
2.18.3 Translate Bio Vaccine Product and Solutions
2.18.4 Translate Bio Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Translate Bio Recent Developments and Future Plans
2.19 Walvax Biotechnology
2.19.1 Walvax Biotechnology Details
2.19.2 Walvax Biotechnology Major Business
2.19.3 Walvax Biotechnology Vaccine Product and Solutions
2.19.4 Walvax Biotechnology Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Walvax Biotechnology Recent Developments and Future Plans
2.20 Wuhan Institute of Biological Products
2.20.1 Wuhan Institute of Biological Products Details
2.20.2 Wuhan Institute of Biological Products Major Business
2.20.3 Wuhan Institute of Biological Products Vaccine Product and Solutions
2.20.4 Wuhan Institute of Biological Products Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Wuhan Institute of Biological Products Recent Developments and Future Plans
2.21 Zoties
2.21.1 Zoties Details
2.21.2 Zoties Major Business
2.21.3 Zoties Vaccine Product and Solutions
2.21.4 Zoties Vaccine Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 Zoties Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Vaccine Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Vaccine by Company Revenue
3.2.2 Top 3 Vaccine Players Market Share in 2023
3.2.3 Top 6 Vaccine Players Market Share in 2023
3.3 Vaccine Market: Overall Company Footprint Analysis
3.3.1 Vaccine Market: Region Footprint
3.3.2 Vaccine Market: Company Product Type Footprint
3.3.3 Vaccine Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Vaccine Consumption Value and Market Share by Type (2019-2024)
4.2 Global Vaccine Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Vaccine Consumption Value Market Share by Application (2019-2024)
5.2 Global Vaccine Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Vaccine Consumption Value by Type (2019-2030)
6.2 North America Vaccine Consumption Value by Application (2019-2030)
6.3 North America Vaccine Market Size by Country
6.3.1 North America Vaccine Consumption Value by Country (2019-2030)
6.3.2 United States Vaccine Market Size and Forecast (2019-2030)
6.3.3 Canada Vaccine Market Size and Forecast (2019-2030)
6.3.4 Mexico Vaccine Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Vaccine Consumption Value by Type (2019-2030)
7.2 Europe Vaccine Consumption Value by Application (2019-2030)
7.3 Europe Vaccine Market Size by Country
7.3.1 Europe Vaccine Consumption Value by Country (2019-2030)
7.3.2 Germany Vaccine Market Size and Forecast (2019-2030)
7.3.3 France Vaccine Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Vaccine Market Size and Forecast (2019-2030)
7.3.5 Russia Vaccine Market Size and Forecast (2019-2030)
7.3.6 Italy Vaccine Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Vaccine Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Vaccine Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Vaccine Market Size by Region
8.3.1 Asia-Pacific Vaccine Consumption Value by Region (2019-2030)
8.3.2 China Vaccine Market Size and Forecast (2019-2030)
8.3.3 Japan Vaccine Market Size and Forecast (2019-2030)
8.3.4 South Korea Vaccine Market Size and Forecast (2019-2030)
8.3.5 India Vaccine Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Vaccine Market Size and Forecast (2019-2030)
8.3.7 Australia Vaccine Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Vaccine Consumption Value by Type (2019-2030)
9.2 South America Vaccine Consumption Value by Application (2019-2030)
9.3 South America Vaccine Market Size by Country
9.3.1 South America Vaccine Consumption Value by Country (2019-2030)
9.3.2 Brazil Vaccine Market Size and Forecast (2019-2030)
9.3.3 Argentina Vaccine Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Vaccine Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Vaccine Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Vaccine Market Size by Country
10.3.1 Middle East & Africa Vaccine Consumption Value by Country (2019-2030)
10.3.2 Turkey Vaccine Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Vaccine Market Size and Forecast (2019-2030)
10.3.4 UAE Vaccine Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Vaccine Market Drivers
11.2 Vaccine Market Restraints
11.3 Vaccine Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Vaccine Industry Chain
12.2 Vaccine Upstream Analysis
12.3 Vaccine Midstream Analysis
12.4 Vaccine Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 5. AstraZeneca Company Information, Head Office, and Major Competitors
Table 6. AstraZeneca Major Business
Table 7. AstraZeneca Vaccine Product and Solutions
Table 8. AstraZeneca Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. AstraZeneca Recent Developments and Future Plans
Table 10. BioNTech Company Information, Head Office, and Major Competitors
Table 11. BioNTech Major Business
Table 12. BioNTech Vaccine Product and Solutions
Table 13. BioNTech Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. BioNTech Recent Developments and Future Plans
Table 15. Boehringer-Ingelheim Company Information, Head Office, and Major Competitors
Table 16. Boehringer-Ingelheim Major Business
Table 17. Boehringer-Ingelheim Vaccine Product and Solutions
Table 18. Boehringer-Ingelheim Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Boehringer-Ingelheim Recent Developments and Future Plans
Table 20. CCBIO Company Information, Head Office, and Major Competitors
Table 21. CCBIO Major Business
Table 22. CCBIO Vaccine Product and Solutions
Table 23. CCBIO Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. CCBIO Recent Developments and Future Plans
Table 25. CSL Company Information, Head Office, and Major Competitors
Table 26. CSL Major Business
Table 27. CSL Vaccine Product and Solutions
Table 28. CSL Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. CSL Recent Developments and Future Plans
Table 30. CureVac Company Information, Head Office, and Major Competitors
Table 31. CureVac Major Business
Table 32. CureVac Vaccine Product and Solutions
Table 33. CureVac Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. CureVac Recent Developments and Future Plans
Table 35. Elanco Company Information, Head Office, and Major Competitors
Table 36. Elanco Major Business
Table 37. Elanco Vaccine Product and Solutions
Table 38. Elanco Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Elanco Recent Developments and Future Plans
Table 40. GSK Company Information, Head Office, and Major Competitors
Table 41. GSK Major Business
Table 42. GSK Vaccine Product and Solutions
Table 43. GSK Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. GSK Recent Developments and Future Plans
Table 45. Hulan Bio Company Information, Head Office, and Major Competitors
Table 46. Hulan Bio Major Business
Table 47. Hulan Bio Vaccine Product and Solutions
Table 48. Hulan Bio Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Hulan Bio Recent Developments and Future Plans
Table 50. Indian Immunologicals Company Information, Head Office, and Major Competitors
Table 51. Indian Immunologicals Major Business
Table 52. Indian Immunologicals Vaccine Product and Solutions
Table 53. Indian Immunologicals Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Indian Immunologicals Recent Developments and Future Plans
Table 55. Merck Company Information, Head Office, and Major Competitors
Table 56. Merck Major Business
Table 57. Merck Vaccine Product and Solutions
Table 58. Merck Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Merck Recent Developments and Future Plans
Table 60. Minhai Biotechnology Company Information, Head Office, and Major Competitors
Table 61. Minhai Biotechnology Major Business
Table 62. Minhai Biotechnology Vaccine Product and Solutions
Table 63. Minhai Biotechnology Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Minhai Biotechnology Recent Developments and Future Plans
Table 65. Mitsubishi Tanabe Pharma Company Information, Head Office, and Major Competitors
Table 66. Mitsubishi Tanabe Pharma Major Business
Table 67. Mitsubishi Tanabe Pharma Vaccine Product and Solutions
Table 68. Mitsubishi Tanabe Pharma Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Mitsubishi Tanabe Pharma Recent Developments and Future Plans
Table 70. Moderna Therapeutics Company Information, Head Office, and Major Competitors
Table 71. Moderna Therapeutics Major Business
Table 72. Moderna Therapeutics Vaccine Product and Solutions
Table 73. Moderna Therapeutics Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Moderna Therapeutics Recent Developments and Future Plans
Table 75. Mylan Company Information, Head Office, and Major Competitors
Table 76. Mylan Major Business
Table 77. Mylan Vaccine Product and Solutions
Table 78. Mylan Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Mylan Recent Developments and Future Plans
Table 80. Plumbline Life Sciences Company Information, Head Office, and Major Competitors
Table 81. Plumbline Life Sciences Major Business
Table 82. Plumbline Life Sciences Vaccine Product and Solutions
Table 83. Plumbline Life Sciences Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Plumbline Life Sciences Recent Developments and Future Plans
Table 85. Sanofi Company Information, Head Office, and Major Competitors
Table 86. Sanofi Major Business
Table 87. Sanofi Vaccine Product and Solutions
Table 88. Sanofi Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Sanofi Recent Developments and Future Plans
Table 90. Translate Bio Company Information, Head Office, and Major Competitors
Table 91. Translate Bio Major Business
Table 92. Translate Bio Vaccine Product and Solutions
Table 93. Translate Bio Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Translate Bio Recent Developments and Future Plans
Table 95. Walvax Biotechnology Company Information, Head Office, and Major Competitors
Table 96. Walvax Biotechnology Major Business
Table 97. Walvax Biotechnology Vaccine Product and Solutions
Table 98. Walvax Biotechnology Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. Walvax Biotechnology Recent Developments and Future Plans
Table 100. Wuhan Institute of Biological Products Company Information, Head Office, and Major Competitors
Table 101. Wuhan Institute of Biological Products Major Business
Table 102. Wuhan Institute of Biological Products Vaccine Product and Solutions
Table 103. Wuhan Institute of Biological Products Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 104. Wuhan Institute of Biological Products Recent Developments and Future Plans
Table 105. Zoties Company Information, Head Office, and Major Competitors
Table 106. Zoties Major Business
Table 107. Zoties Vaccine Product and Solutions
Table 108. Zoties Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 109. Zoties Recent Developments and Future Plans
Table 110. Global Vaccine Revenue (USD Million) by Players (2019-2024)
Table 111. Global Vaccine Revenue Share by Players (2019-2024)
Table 112. Breakdown of Vaccine by Company Type (Tier 1, Tier 2, and Tier 3)
Table 113. Market Position of Players in Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 114. Head Office of Key Vaccine Players
Table 115. Vaccine Market: Company Product Type Footprint
Table 116. Vaccine Market: Company Product Application Footprint
Table 117. Vaccine New Market Entrants and Barriers to Market Entry
Table 118. Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 119. Global Vaccine Consumption Value (USD Million) by Type (2019-2024)
Table 120. Global Vaccine Consumption Value Share by Type (2019-2024)
Table 121. Global Vaccine Consumption Value Forecast by Type (2025-2030)
Table 122. Global Vaccine Consumption Value by Application (2019-2024)
Table 123. Global Vaccine Consumption Value Forecast by Application (2025-2030)
Table 124. North America Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 125. North America Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 126. North America Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 127. North America Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 128. North America Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 129. North America Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 130. Europe Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 131. Europe Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 132. Europe Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 133. Europe Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 134. Europe Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 135. Europe Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 136. Asia-Pacific Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 137. Asia-Pacific Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 138. Asia-Pacific Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 139. Asia-Pacific Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 140. Asia-Pacific Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 141. Asia-Pacific Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 142. South America Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 143. South America Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 144. South America Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 145. South America Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 146. South America Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 147. South America Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 148. Middle East & Africa Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 149. Middle East & Africa Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 150. Middle East & Africa Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 151. Middle East & Africa Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 152. Middle East & Africa Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 153. Middle East & Africa Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 154. Vaccine Raw Material
Table 155. Key Suppliers of Vaccine Raw Materials
Table 1. Global Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 5. AstraZeneca Company Information, Head Office, and Major Competitors
Table 6. AstraZeneca Major Business
Table 7. AstraZeneca Vaccine Product and Solutions
Table 8. AstraZeneca Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. AstraZeneca Recent Developments and Future Plans
Table 10. BioNTech Company Information, Head Office, and Major Competitors
Table 11. BioNTech Major Business
Table 12. BioNTech Vaccine Product and Solutions
Table 13. BioNTech Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. BioNTech Recent Developments and Future Plans
Table 15. Boehringer-Ingelheim Company Information, Head Office, and Major Competitors
Table 16. Boehringer-Ingelheim Major Business
Table 17. Boehringer-Ingelheim Vaccine Product and Solutions
Table 18. Boehringer-Ingelheim Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Boehringer-Ingelheim Recent Developments and Future Plans
Table 20. CCBIO Company Information, Head Office, and Major Competitors
Table 21. CCBIO Major Business
Table 22. CCBIO Vaccine Product and Solutions
Table 23. CCBIO Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. CCBIO Recent Developments and Future Plans
Table 25. CSL Company Information, Head Office, and Major Competitors
Table 26. CSL Major Business
Table 27. CSL Vaccine Product and Solutions
Table 28. CSL Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. CSL Recent Developments and Future Plans
Table 30. CureVac Company Information, Head Office, and Major Competitors
Table 31. CureVac Major Business
Table 32. CureVac Vaccine Product and Solutions
Table 33. CureVac Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. CureVac Recent Developments and Future Plans
Table 35. Elanco Company Information, Head Office, and Major Competitors
Table 36. Elanco Major Business
Table 37. Elanco Vaccine Product and Solutions
Table 38. Elanco Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Elanco Recent Developments and Future Plans
Table 40. GSK Company Information, Head Office, and Major Competitors
Table 41. GSK Major Business
Table 42. GSK Vaccine Product and Solutions
Table 43. GSK Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. GSK Recent Developments and Future Plans
Table 45. Hulan Bio Company Information, Head Office, and Major Competitors
Table 46. Hulan Bio Major Business
Table 47. Hulan Bio Vaccine Product and Solutions
Table 48. Hulan Bio Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Hulan Bio Recent Developments and Future Plans
Table 50. Indian Immunologicals Company Information, Head Office, and Major Competitors
Table 51. Indian Immunologicals Major Business
Table 52. Indian Immunologicals Vaccine Product and Solutions
Table 53. Indian Immunologicals Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Indian Immunologicals Recent Developments and Future Plans
Table 55. Merck Company Information, Head Office, and Major Competitors
Table 56. Merck Major Business
Table 57. Merck Vaccine Product and Solutions
Table 58. Merck Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Merck Recent Developments and Future Plans
Table 60. Minhai Biotechnology Company Information, Head Office, and Major Competitors
Table 61. Minhai Biotechnology Major Business
Table 62. Minhai Biotechnology Vaccine Product and Solutions
Table 63. Minhai Biotechnology Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Minhai Biotechnology Recent Developments and Future Plans
Table 65. Mitsubishi Tanabe Pharma Company Information, Head Office, and Major Competitors
Table 66. Mitsubishi Tanabe Pharma Major Business
Table 67. Mitsubishi Tanabe Pharma Vaccine Product and Solutions
Table 68. Mitsubishi Tanabe Pharma Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Mitsubishi Tanabe Pharma Recent Developments and Future Plans
Table 70. Moderna Therapeutics Company Information, Head Office, and Major Competitors
Table 71. Moderna Therapeutics Major Business
Table 72. Moderna Therapeutics Vaccine Product and Solutions
Table 73. Moderna Therapeutics Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Moderna Therapeutics Recent Developments and Future Plans
Table 75. Mylan Company Information, Head Office, and Major Competitors
Table 76. Mylan Major Business
Table 77. Mylan Vaccine Product and Solutions
Table 78. Mylan Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Mylan Recent Developments and Future Plans
Table 80. Plumbline Life Sciences Company Information, Head Office, and Major Competitors
Table 81. Plumbline Life Sciences Major Business
Table 82. Plumbline Life Sciences Vaccine Product and Solutions
Table 83. Plumbline Life Sciences Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Plumbline Life Sciences Recent Developments and Future Plans
Table 85. Sanofi Company Information, Head Office, and Major Competitors
Table 86. Sanofi Major Business
Table 87. Sanofi Vaccine Product and Solutions
Table 88. Sanofi Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Sanofi Recent Developments and Future Plans
Table 90. Translate Bio Company Information, Head Office, and Major Competitors
Table 91. Translate Bio Major Business
Table 92. Translate Bio Vaccine Product and Solutions
Table 93. Translate Bio Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Translate Bio Recent Developments and Future Plans
Table 95. Walvax Biotechnology Company Information, Head Office, and Major Competitors
Table 96. Walvax Biotechnology Major Business
Table 97. Walvax Biotechnology Vaccine Product and Solutions
Table 98. Walvax Biotechnology Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. Walvax Biotechnology Recent Developments and Future Plans
Table 100. Wuhan Institute of Biological Products Company Information, Head Office, and Major Competitors
Table 101. Wuhan Institute of Biological Products Major Business
Table 102. Wuhan Institute of Biological Products Vaccine Product and Solutions
Table 103. Wuhan Institute of Biological Products Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 104. Wuhan Institute of Biological Products Recent Developments and Future Plans
Table 105. Zoties Company Information, Head Office, and Major Competitors
Table 106. Zoties Major Business
Table 107. Zoties Vaccine Product and Solutions
Table 108. Zoties Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 109. Zoties Recent Developments and Future Plans
Table 110. Global Vaccine Revenue (USD Million) by Players (2019-2024)
Table 111. Global Vaccine Revenue Share by Players (2019-2024)
Table 112. Breakdown of Vaccine by Company Type (Tier 1, Tier 2, and Tier 3)
Table 113. Market Position of Players in Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 114. Head Office of Key Vaccine Players
Table 115. Vaccine Market: Company Product Type Footprint
Table 116. Vaccine Market: Company Product Application Footprint
Table 117. Vaccine New Market Entrants and Barriers to Market Entry
Table 118. Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 119. Global Vaccine Consumption Value (USD Million) by Type (2019-2024)
Table 120. Global Vaccine Consumption Value Share by Type (2019-2024)
Table 121. Global Vaccine Consumption Value Forecast by Type (2025-2030)
Table 122. Global Vaccine Consumption Value by Application (2019-2024)
Table 123. Global Vaccine Consumption Value Forecast by Application (2025-2030)
Table 124. North America Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 125. North America Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 126. North America Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 127. North America Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 128. North America Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 129. North America Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 130. Europe Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 131. Europe Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 132. Europe Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 133. Europe Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 134. Europe Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 135. Europe Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 136. Asia-Pacific Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 137. Asia-Pacific Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 138. Asia-Pacific Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 139. Asia-Pacific Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 140. Asia-Pacific Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 141. Asia-Pacific Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 142. South America Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 143. South America Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 144. South America Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 145. South America Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 146. South America Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 147. South America Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 148. Middle East & Africa Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 149. Middle East & Africa Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 150. Middle East & Africa Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 151. Middle East & Africa Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 152. Middle East & Africa Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 153. Middle East & Africa Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 154. Vaccine Raw Material
Table 155. Key Suppliers of Vaccine Raw Materials
LIST OF FIGURES
Figure 1. Vaccine Picture
Figure 2. Global Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Varicella Vaccine
Figure 5. Influenza Vaccine
Figure 6. Polio Vaccine
Figure 7. Hepatitis A Vaccine
Figure 8. Rabies Vaccine
Figure 9. BCG Vaccine
Figure 10. Hepatitis B
Figure 11. Pertussis, Diphtheria, Tetanus
Figure 12. Pneumococcal
Figure 13. Others
Figure 14. Global Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 15. Vaccine Consumption Value Market Share by Application in 2023
Figure 16. For Adult Picture
Figure 17. For Child Picture
Figure 18. Global Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 19. Global Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 20. Global Market Vaccine Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 21. Global Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 22. Global Vaccine Consumption Value Market Share by Region in 2023
Figure 23. North America Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East and Africa Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Vaccine Revenue Share by Players in 2023
Figure 29. Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 30. Global Top 3 Players Vaccine Market Share in 2023
Figure 31. Global Top 6 Players Vaccine Market Share in 2023
Figure 32. Global Vaccine Consumption Value Share by Type (2019-2024)
Figure 33. Global Vaccine Market Share Forecast by Type (2025-2030)
Figure 34. Global Vaccine Consumption Value Share by Application (2019-2024)
Figure 35. Global Vaccine Market Share Forecast by Application (2025-2030)
Figure 36. North America Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 37. North America Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 38. North America Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 40. Canada Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 41. Mexico Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 42. Europe Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 43. Europe Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 44. Europe Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 46. France Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 47. United Kingdom Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 48. Russia Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 49. Italy Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 53. China Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 54. Japan Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 55. South Korea Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 56. India Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 57. Southeast Asia Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 58. Australia Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 59. South America Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 60. South America Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 61. South America Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 63. Argentina Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 64. Middle East and Africa Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 65. Middle East and Africa Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 66. Middle East and Africa Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 67. Turkey Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 68. Saudi Arabia Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 69. UAE Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 70. Vaccine Market Drivers
Figure 71. Vaccine Market Restraints
Figure 72. Vaccine Market Trends
Figure 73. Porters Five Forces Analysis
Figure 74. Manufacturing Cost Structure Analysis of Vaccine in 2023
Figure 75. Manufacturing Process Analysis of Vaccine
Figure 76. Vaccine Industrial Chain
Figure 77. Methodology
Figure 78. Research Process and Data Source
Figure 1. Vaccine Picture
Figure 2. Global Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Varicella Vaccine
Figure 5. Influenza Vaccine
Figure 6. Polio Vaccine
Figure 7. Hepatitis A Vaccine
Figure 8. Rabies Vaccine
Figure 9. BCG Vaccine
Figure 10. Hepatitis B
Figure 11. Pertussis, Diphtheria, Tetanus
Figure 12. Pneumococcal
Figure 13. Others
Figure 14. Global Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 15. Vaccine Consumption Value Market Share by Application in 2023
Figure 16. For Adult Picture
Figure 17. For Child Picture
Figure 18. Global Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 19. Global Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 20. Global Market Vaccine Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 21. Global Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 22. Global Vaccine Consumption Value Market Share by Region in 2023
Figure 23. North America Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East and Africa Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Vaccine Revenue Share by Players in 2023
Figure 29. Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 30. Global Top 3 Players Vaccine Market Share in 2023
Figure 31. Global Top 6 Players Vaccine Market Share in 2023
Figure 32. Global Vaccine Consumption Value Share by Type (2019-2024)
Figure 33. Global Vaccine Market Share Forecast by Type (2025-2030)
Figure 34. Global Vaccine Consumption Value Share by Application (2019-2024)
Figure 35. Global Vaccine Market Share Forecast by Application (2025-2030)
Figure 36. North America Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 37. North America Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 38. North America Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 40. Canada Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 41. Mexico Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 42. Europe Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 43. Europe Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 44. Europe Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 46. France Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 47. United Kingdom Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 48. Russia Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 49. Italy Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 53. China Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 54. Japan Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 55. South Korea Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 56. India Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 57. Southeast Asia Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 58. Australia Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 59. South America Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 60. South America Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 61. South America Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 63. Argentina Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 64. Middle East and Africa Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 65. Middle East and Africa Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 66. Middle East and Africa Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 67. Turkey Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 68. Saudi Arabia Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 69. UAE Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 70. Vaccine Market Drivers
Figure 71. Vaccine Market Restraints
Figure 72. Vaccine Market Trends
Figure 73. Porters Five Forces Analysis
Figure 74. Manufacturing Cost Structure Analysis of Vaccine in 2023
Figure 75. Manufacturing Process Analysis of Vaccine
Figure 76. Vaccine Industrial Chain
Figure 77. Methodology
Figure 78. Research Process and Data Source
